1. Phase I Pharmacokinetic and Pharmacodynamic Study of Temozolomide in Pediatric Patients With Refractory or Recurrent Leukemia: A Children's Oncology Group Study
   Terzah M. Horton et al, 2007, Journal of Clinical Oncology CrossRef
2. CpG Island Methylator Phenotype Redefines the Prognostic Effect of t(12;21) in Childhood Acute Lymphoblastic Leukemia
   Jose Roman-Gomez et al, 2006, Clinical Cancer Research CrossRef
3. Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia
   Narges Aberuyi et al, 2020, Frontiers in Oncology CrossRef
4. Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
   Huan Xu et al, 2021, Cells CrossRef
5. DNA Methylation of Tumor Suppressor Genes in Clinical Remission Predicts the Relapse Risk in Acute Myeloid Leukemia
   Shuchi Agrawal et al, 2007, Cancer Research CrossRef
6. Large-Scale CpG Methylation Analysis Identifies Novel Candidate Genes and Reveals Methylation Hotspots in Acute Lymphoblastic Leukemia
   Kristen H. Taylor et al, 2007, Cancer Research CrossRef
7. Genetics and epigenetics of pediatric leukemia in the era of precision medicine
   Kristie N Ramos et al, 2018, F1000Research CrossRef